# Evaluation of FLT-PET and DWI-MRI in Patients With NSCLC Treated With a Platinum-based Doublet as Preoperative Chemo

> **NCT02273271** · NA · UNKNOWN · sponsor: **European Organisation for Research and Treatment of Cancer - EORTC** · enrollment: 31 (estimated)

## Conditions studied

- Non-small Cell Lung Carcinoma

## Interventions

- **OTHER:** 18F-FLT-PET/CT and DWI-MRI

## Key facts

- **NCT ID:** NCT02273271
- **Lead sponsor:** European Organisation for Research and Treatment of Cancer - EORTC
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-10
- **Primary completion:** 2016-12
- **Final completion:** 2017-02
- **Target enrollment:** 31 (ESTIMATED)
- **Last updated:** 2015-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02273271

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02273271, "Evaluation of FLT-PET and DWI-MRI in Patients With NSCLC Treated With a Platinum-based Doublet as Preoperative Chemo". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02273271. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*